Europe Balks At Support For Collider

WASHINGTON—European scientists testifying before a House committee have thrown cold water on the prospect of international collaboration on the Superconducting Supercollider, a possibility that the Reagan administration has held out as a way to reduce the U.S. cost of the proposed multi-billion dollar project. In three days of hearings last month by the Science, Technology and Space Committee, a stream of witnesses also expressed doubts about the value of recently discovered superconductiv

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In three days of hearings last month by the Science, Technology and Space Committee, a stream of witnesses also expressed doubts about the value of recently discovered superconductive materials in the design of the project and concern about the short timetable for site selection and the massive project's impact on the rest of science and the federal deficit.

Herwig Schopper, director-general of CERN, provided a grim scenario for the SSC based on a scarcity of funds available for science in Europe. "If we would propose such a project of that size, it would not go through because the emphasis [in Europe] is on costefficiency and cost-effectiveness," he said.

Schopper advocated a less energetic hadron, or proton, collider reaching about 9 TeV in each beam to sit above the ring of magnets for CERN's Large Electron-Positron (LEP) collider, a circular electron accelerator slated to begin operation in early 1989. "The hadron ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Therese Lloyd

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo